Table 1.
The characteristics of include studies
| Style | CPR(%) | HQER(%) | LBR(%) | BPR(%) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | Location | Mean age(years) | N(A/C) | A | C | A | C | A | C | A | C | A | C | ||||
| Wu 2022 [31] | China | 29 | 83(40/43) | MA | No Acupuncture | 72.5 | 48.8 | + | 30.0 | 16.3 | - | ||||||
| Rashidi 2013 [30] | Iran | 31 | 62(31/31) | MA | No Acupuncture | 25.8 | 16.1 | - | 3.75; 0.45 | 3.5; 0.82 | + | 25.8 | 16.1 | - | |||
| Altutunji 2019 [29] | China | Unclear | 102(33/69) | MA | No Acupuncture | 33.33 | 14.5 | + | 42.40 | 21.70 | - | ||||||
| Chen 2009 [23] | China | 32.4 | 96(50/46) | EA | No Acupuncture | 37.77 | 31.07 | - | 63.53 | 50.11 | + | ||||||
| Li 2015 [22] | China | 31 | 217(119/98) | EA | No Acupuncture | 53.19 | 44.83 | - | 50.81 | 42.33 | + | ||||||
| Xing 2022 [27] | China | 34 | 68(34/34) | MA | No Acupuncture | 67.6 | 38.2 | + | 64.7 | 35.3 | + | 32.4 | 61.8 | + | |||
| Wu 2021 [26] | China | 31 | 100(50/50) | MA | No Acupuncture | 56 | 36 | - | 70.24 ± 24.79 | 48.79 ± 25.52 | + | ||||||
| Ye 2020 [28] | China | 29 | 83(40/43) | MA | No Acupuncture | 72.5 | 48.8 | + | 30 | 16.3 | - | ||||||
| Li 2011 [25] | China | 28 | 62(31/31) | EA | SA | 56 | 49 | + | 70 | 62 | + | ||||||
| Guo 2022 [24] | China | 30.16 | 100(50/50) | EA + Meds | Meds | 75 | 58 | + | 82.3 | 70.3 | + | ||||||
| Li 2012 [32] | China | 29.9 | 141(74/67) | EA | No Acupuncture | 48.48 | 37.70 | - | 61.52 ± 22.20 | 50.55 ± 16.15 | + | ||||||
| Li 2009 [33] | China | 32.56 | 43(23/20) | EA | No Acupuncture | 45.67 | 37.93 | - | 60.2 ± 22.20 | 50.55 ± 16.15 | + | ||||||
| OPR(%) | MR(%) | Endometrial thickness (mm) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | A | C | A | C | A | C | Points needled | Frequency of treatment (in a week) | The total number of treatments (Menstrual Cycle) | |||
| Wu 2022 [31] | 9.77 ± 2.59 | 9.3 ± 1.98 | - | 11 | 4 | 3 | ||||||
| Rashidi 2013 [30] | 19.4 | 16.1 | - | 6.6 | 3.3 | - | 8 | < 1 | ||||
| Altutunji 2019 [29] | 33.30 | 14.50 | - | 0 | 2.90 | + | 10.4 ± 1.98 | 10.3 ± 2.05 | - | 15 | 7 | 1 ~ 2 |
| Chen 2009 [23] | 9 | 7 | 1 ~ 2 | |||||||||
| Li 2015 [22] | 4.0 | 5.13 | - | 6 | 5 | 1 ~ 2 | ||||||
| Xing 2022 [27] | 4.98 ± 0.71 | 5.23 ± 0.76 | + |
10/10/9/9 (4 stages) |
3 | 3 | ||||||
| Wu 2021 [26] | 2.01 ± 0.25 | 1.20 ± 0.24 | + | 11 | 4 | 3 | ||||||
| Ye 2020 [28] | 9.77 ± 2.59 | 9.39 ± 1.98 | - | 12 | 4 | 1 ~ 2 | ||||||
| Li 2011 [25] | 6 | 4 | < 1 | |||||||||
| Guo 2022 [24] | 6 | 10 | + | 12 | 7 | < 1 | ||||||
| Li 2012 [32] | 9.7 ± 1.8 | 10.00 ± 1.2 | - | 10 | 5 | 1 ~ 2 | ||||||
| Li 2009 [33] | 10.5 ± 1.3 | 10.00 ± 1.6 | - | 8 | 5 | 1 ~ 2 | ||||||
MA Manual Acupuncture, EA Electroacupuncture, SA Sham acupuncture, Meds Medicines, N(A/C) Numbers(Acupuncture group/Control group), A Acupuncture group, C Control group, CPR Clinical pregnancy rate, HQER High-quality embryo rate, LBR Live birth rate, BPR Bochemical pregnancy rate, OPR Ongoing pregnancy rate, MR Miscarriage rate
+ : Between-group differences were statistically significant (P < 0.01, P < 0.05)
-: Between-group differences were no statistically significant (P > 0.05)